Aurobindo Pharma USA Inc 2024-12-11 Health serious FDA
Health · FDA · Recall #FDA-D-0078-2025
Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b)… Recall
Issued December 11, 2024 · Aurobindo Pharma USA Inc
In December 2024, Aurobindo Pharma USA Inc recalled the Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b)…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
What you should do
- 1 Stop using Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b)… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Aurobindo Pharma USA Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Aurobindo Pharma USA Inc
- Category
- Health
- Recall date
- December 11, 2024
- Units affected
- Not reported
- Sold at
- USA Nationwide
- Recall number
- FDA-D-0078-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Aurobindo Pharma USA Inc has 3 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.